DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Blarcamesine
Blarcamesine
Parkinson Disease-Associated Cognitive Impairment
Blarcamesine | Medchemexpress
Neural Regeneration Research
Mtdls) Binding the Σ1 Receptor As Promising Therapeutics: State of the Art and Perspectives
Effects of the Sigma-1 Receptor Agonist Blarcamesine in a Murine Model Of
A Business Development Look at the Cns Landscape
Bi-Phasic Dose Response in the Preclinical and Clinical Developments of Sigma-1 Receptor Ligands for the Treatment of Neurodegenerative Disorders Tangui Maurice
Horizon Scanning Status Report December 2020
CTAD POSTER 2019-1.Pdf
Horizon Scanning Status Report June 2020 Prepared For: Patient-Centered Outcomes Research Institute 1828 L St., NW, Suite 900 Washington, DC 20036
Lung Defects Contribute to Respiratory Symptoms in a Mecp2-Mutant Mouse Model of Rett Syndrome
An Emerging Role for Sigma-1 Receptors in the Treatment of Developmental and Epileptic Encephalopathies
Muscarinic Acetylcholine Receptor M2
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
Muscarinic Acetylcholine Receptor
Advances in Understanding of Rett Syndrome and MECP2 Duplication Syndrome: Prospects for Future Therapies
Bioactive Compound Library Plus (96-Well)
Sigma-1 Receptor (S1R) Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in Neurodegenerative Diseases
Top View
Treatment of Parkinson's Disease with Cognitive Impairment
13Th Clinical Trials on Alzheimer's Disease (CTAD) November 4-7, 2020
2021 Medicines in Development: Health Equity
Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
Expanding the MECP2 Network Using Comparative Genomics Reveals
A Sigma-1 Receptor Agonist, Ameliorates Neurologic Impairments in a Mouse Model of Rett Syndrome T ⁎ Walter E
Rett Failure Sets up Thin Pipeline